Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.41 |
| ▸ | FABP7 | O15540 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31047777 | 0.90 | KMT2A (0.44) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL28458423 | 0.90 | KMT2A (0.44) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL4690511 | 0.85 | KMT2A (0.47) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL12187737 | 0.83 | KMT2A (0.64) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL30935801 | 0.82 | FABP5 (0.43) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL31540857 | 0.82 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| Hydrochloric Acid SCHEMBL18981946 | 0.82 | KMT2A (0.62) | KMT2AFABP5FABP7CA1CA2 | |
| Hydrochloric Acid SCHEMBL31540856 | 0.81 | KMT2A (0.49) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL9511258 | 0.81 | CASP3 (0.44) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL26941528 | 0.81 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114958-A1 | INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS | Vertex Pharmceuticals Incorporated (US) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008106139-A1 | INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-09-04 | — | — | WO | disclosed |